Adults With Obesity More Likely to Ration Drugs to Save Money. Adults with obesity are more likely to ration their ...

SAN ANTONIO — Several types of anti-obesity medications (AOMs), including glucagon-like peptide 1s (GLP-1s), are associated ...

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...

Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications.

That’s according to a clinical trial conducted in 11 countries — the first of its kind to show that one of the wave of ...

A new study examining a large sample of privately insured patients with obesity found that use of drugs such as Ozempic and Wegovy as anti-obesity medications more than doubled from 2022 to 2023.

The clinical-stage drugmaker is developing an anti-obesity drug that could go on to produce record-breaking sales. Viking's ...

Weight-loss drugs, particularly newer options like GLP-1 receptor agonists, are revolutionising the treatment of obesity and ...

Popular GLP-1 drugs are already known to have many benefits, but scientists continue to explore what else they — and their ...